Mark Nelson, Ph.D., UVM Distinguished Professor and Chair of Pharmacology. (Photo: Medical Communications)
Internationally recognized cerebral blood flow expert and University of Vermont Distinguished Professor and Chair of Pharmacology Mark Nelson, Ph.D., delivered a National Institutes of Health (NIH) Director’s Wednesday Afternoon Lecture on October 14. Titled “Translating Thought into Blood Flow in the Brain: Capillaries as Sensors of Neural Activity,” the lecture is open to the public and available via livestream at videocast.nih.gov .
A UVM faculty member since 1986, Nelson is an elected member of the prestigious National Academy of Sciences and a Fellow of both the American Heart Association and the Biophysical Society. He is the recipient of an Outstanding Investigator Award from the NIH’s National Heart, Lung and Blood Institute and an NIH MERIT award and has served on many NIH study sections, including as a Regular Member, averaging one to two study sections per year.
About the Lecture Topic
Healthy brain function depends on the finely tuned spatial and temporal delivery of blood-borne nutrients to active neurons via the vast, dense capillary network. Cerebral small vessel diseases (SVDs) are a central link between stroke and dementia—two co-morbidities that rank among the most pressing human health issues. Despite the emerging consensus that SVDs are initiated in the endothelium, the early molecular mechanisms remain largely unknown and no specific treatments are yet available. Deficits in on-demand delivery of blood to active brain regions (functional hyperemia) have been identified as early manifestations of the underlying pathogenesis. The strong inward-rectifier K+ channel (Kir2.1) in capillary endothelial cells, which senses neuronal activity and initiates a propagating electrical signal that dilates upstream arterioles, is a cornerstone of this functional hyperemia mechanism. However, whether this mechanism is targeted in SVDs and how resulting signaling deficits might be rescued remains unknown. Using a genetic mouse model of the most common hereditary SVD (CADASIL, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy), we show that impaired functional hyperemia is caused by a complete loss of capillary-to-arteriole electrical signaling due to diminished capillary endothelial Kir2.1 channel activity. We further linked Kir2.1 deactivation to depletion of phosphatidylinositol 4,5-bisphosphate (PIP2), a membrane phospholipid essential for Kir2.1 activity. Strikingly, systemic injection of soluble PIP2 rapidly restored functional hyperemia in SVD, suggesting a possible strategy for rescuing functional hyperemia in brain disorders in which blood flow is disturbed. (Source: NIH Director's Wednesday Afternoon Lecture Series)